Back

Characteristics, outcomes, and risk stratification in obese vs. non-obese patients with pulmonary arterial hypertension

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 4 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Giulio Savonitto

Karolinska Institutet, Stockholm (Italy)

6 More presentations in this session

Presentation thumbnail
Exploring and managing pulmonary hypertension in congenital heart defects: a challenging path
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Unveiling the interplay of pulmonary hypertension parameters from right heart catheterization with cardiopulmonary exercise testing in heart failure patients
Doctor A. Ribeiro Teixeira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Unmasking exercise pulmonary hypertension - does time matter?
Doctor J. Mirinha Luz (Almada, PT)
Abstract Slides Video
Presentation thumbnail
The unusual suspect. Is pulmonary veno-occlusive disease underrecognized?
Mr D. Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Early treatment failure in incident pulmonary arterial hypertension
Doctor G. Savonitto (Stockholm, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Patients hospitalised due to acute heart failure: baseline characteristics, clinical presentation, echocardiographic data and outcomes among the body mass index categories
thumbnail
Congress Presentation
Prognostic nutritional index: as a new predictor of mortality in pulmonary arterial hypertension Patients
thumbnail
Congress Presentation
Association between body mass index, left ventricular remodeling, and long term outcome in patients with bicuspid aortic valve

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources